Device Studies
PRECISION II STUDY
The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System
Who Can Participate
- Between the ages of 18-75 years
- Within 3 months of Type 1 or Type 2 diabetes diagnosis and is being treated with insulin injections in the form of multiple daily injections or through insulin infusion pump
Joslin Diabetes Center, Boston, MA
EVERSENSE
Eversense® Non-adjunctive Use Post Approval Study (NA-PAS)
Green Mountain Research Institute, Rutland, VT
The CIAO Study
- The safety and scientific validity of a research study is the responsibility of the study investigators and the study sponsor.
- It is important to evaluate the risks and potential benefits of clinical studies and to talk to your health care provider(s) before participating in a study.